caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1811179542

Jazeela FayyazD.O.

Pulmonary DiseaseRochester, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Jazeela Fayyaz's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 17 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ACM MEDICAL LABORATORY INC90467
THE UNITY HOSPITAL OF ROCHESTER86297
ROCHESTER GENERAL HOSPITAL59247
DIRISIO, LESLIE52143
UNIVERSITY OF ROCHESTER47113
James Murray
Pulmonary Disease · Rochester, NY
4298
Lauren Newson
Nurse Practitioner · Rochester, NY
4072
Sandeep Naidu
Diagnostic Radiology · Orlando, FL
3688
Jason Lyons
Pulmonary Disease · Rochester, NY
3691
Jennifer Stalica
Pulmonary Disease · Rochester, NY
3378
Nathan Ritter
Cardiology · Rochester, NY
2237
Sarah Vanderlinde
Diagnostic Radiology · Rochester, NY
2041
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
170
Unique beneficiaries
—
Total services
192
Distinct HCPCS
8
Medicare payment
$8K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 811 Pulmonary Disease providers in NY — bottom quintile (cohort median 790).
PRESCRIBING · PART D · 2024
Total Rx claims
1,543
Beneficiaries
—
Total drug cost
$880K
Distinct drugs
28
Brand share
67.0%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter426 claims
Prednisone129 claims
Azithromycin125 claims
Albuterol Sulfate91 claims
Beclomethasone Dipropionate85 claims
QUALITY · MIPS · 2024
Final MIPS score
96.6
Quality
74.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.91%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$576
Payment records
26
By payment type
Food and Beverage$576